Skip to main navigation Skip to search Skip to main content

Equity and representativeness in pragmatic drug trials: methodological and ethical considerations

  • Rafael Dal-Re*
  • , Ana Abreu
  • , Tor Biering-Sorensen
  • , Christopher P. Gale
  • , Sigrun Halvorsen
  • , Soren Holm
  • , Borja Ibanez
  • , Stefan James
  • , Roberto Latini
  • , David Shaw
  • *Corresponding author for this work

Research output: Contribution to journal › Editorial › Academic › peer-review

Original languageEnglish
Number of pages6
JournalBMJ Evidence-Based Medicine: expertise, values, evidence
DOIs
Publication statusE-pub ahead of print - 2026

Keywords

  • Cardiovascular Diseases
  • Ethics
  • Drug Development
  • PARTICIPANTS
  • RATIONALE
  • DESIGN

Cite this